Chronic myeloid leukemia (CML) is a hematopoietic stem cell malignancy characterized by the presence of the (9; 22) (BCR-ABL1) fusion gene [104]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.